Marcia Craib

554 total citations
6 papers, 422 citations indexed

About

Marcia Craib is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Marcia Craib has authored 6 papers receiving a total of 422 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Pulmonary and Respiratory Medicine, 2 papers in Oncology and 1 paper in Surgery. Recurrent topics in Marcia Craib's work include Cystic Fibrosis Research Advances (3 papers), PARP inhibition in cancer therapy (2 papers) and Tracheal and airway disorders (2 papers). Marcia Craib is often cited by papers focused on Cystic Fibrosis Research Advances (3 papers), PARP inhibition in cancer therapy (2 papers) and Tracheal and airway disorders (2 papers). Marcia Craib collaborates with scholars based in United States, Greece and United Kingdom. Marcia Craib's co-authors include Michael W. Konstan, David J. Pasta, Wayne J. Morgan, Dennis C. Stokes, Warren E. Regelmann, Steven M. Butler, Jeffrey S. Wagener, Charles A. Johnson, Mary Ellen B. Wohl and Michael S. Schechter and has published in prestigious journals such as Journal of Clinical Oncology, Medicine & Science in Sports & Exercise and The Journal of Pediatrics.

In The Last Decade

Marcia Craib

5 papers receiving 416 citations

Peers

Marcia Craib

PRM

EPIDE

PHYSI

MB

SH

Martina Contarini Italy

Latifa Patel United Kingdom

Jill M. VanDalfsen United States

Natalia Cirilli Italy

Alastair Reid United Kingdom

Richard Kronmal United States

Bernadette Prentice Australia

Ermanno Baldo Italy

Paul H. Sammut United States

Andrea Browatzki Denmark

Martina Contarini Italy

Marcia Craib

309 ×0.8

PRM

72 ×1.1

EPIDE

44 ×1.0

PHYSI

33 ×0.8

MB

27 ×1.0

SH

Citations per year, relative to Marcia Craib Marcia Craib (= 1×) peers Martina Contarini

Countries citing papers authored by Marcia Craib

Since Specialization

Citations

This map shows the geographic impact of Marcia Craib's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marcia Craib with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marcia Craib more than expected).

Fields of papers citing papers by Marcia Craib

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marcia Craib. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marcia Craib. The network helps show where Marcia Craib may publish in the future.

Co-authorship network of co-authors of Marcia Craib

This figure shows the co-authorship network connecting the top 25 collaborators of Marcia Craib. A scholar is included among the top collaborators of Marcia Craib based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marcia Craib. Marcia Craib is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Anbil, Sriram, Nicholas J. Seewald, E. Gabriela Chiorean, et al.. (2025). LODESTAR: A Single-Arm Phase II Study of Rucaparib in Solid Tumors With Pathogenic Germline or Somatic Variants in Homologous Recombination Repair Genes. JCO Precision Oncology. 9(9). e2500090–e2500090.

2.

O’Malley, David M., Bradley Monk, Myong Cheol Lim, et al.. (2024). Final safety results from ATHENA–MONO (GOG-3020/ENGOT-ov45), a randomized, placebo-controlled, double-blind, phase 3 trial evaluating rucaparib monotherapy as maintenance treatment in patients with newly diagnosed ovarian cancer.. Journal of Clinical Oncology. 42(16_suppl). 5554–5554. 4 indexed citations

3.

McColley, Susanna A., Michael S. Schechter, Wayne J. Morgan, et al.. (2017). Risk factors for mortality before age 18 years in cystic fibrosis. Pediatric Pulmonology. 52(7). 909–915. 69 indexed citations

4.

VanDevanter, Donald R., Marcia Craib, David J. Pasta, et al.. (2017). Cystic fibrosis clinical characteristics associated with dornase alfa treatment regimen change. Pediatric Pulmonology. 53(1). 43–49. 6 indexed citations

5.

Konstan, Michael W., Wayne J. Morgan, Steven M. Butler, et al.. (2007). Risk Factors For Rate of Decline in Forced Expiratory Volume in One Second in Children and Adolescents with Cystic Fibrosis. The Journal of Pediatrics. 151(2). 134–139.e1. 342 indexed citations

6.

Craib, Marcia, et al.. (1999). ELEVATED SERUM CYTOKINES ASSOCIATED WITH PLANTAR FASCIITIS. Medicine & Science in Sports & Exercise. 31(Supplement). S60–S60. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact